Three genes—ACAT1, MAP3K11, and PSMD12—support #enzalutamide resistance in castration-resistant #ProstateCancer cells in vitro. @CWRUSOM @Sarah_Kohrt1 @AwadallahWisam @R_Phillips_3 @JagpreetNanda @PCuroMD @mmgrabow https://t.co/fUahDMBfIC https://t.co/Xh
Three genes—ACAT1, MAP3K11, and PSMD12—support #enzalutamide resistance in castration-resistant #ProstateCancer cells in vitro. @CWRUSOM @Sarah_Kohrt1 @AwadallahWisam @R_Phillips_3 @JagpreetNanda @PCuroMD mmgrabow https://t.co/RKwSM45yhv https://t.co/tnA
Three genes— ACAT1, MAP3K11, and PSMD12— support #enzalutamide resistance in castration-resistant #ProstateCancer cells in vitro. @CWRUSOM @Sarah_Kohrt1 @AwadallahWisam @R_Phillips_3 @JagpreetNanda @PCuroMD mmgrabow https://t.co/9nzTslUGaz https://t.co/8
Three genes— ACAT1, MAP3K11, and PSMD12— support #enzalutamide resistance in castration-resistant #ProstateCancer cells in vitro. @CWRUSOM @Sarah_Kohrt1 @AwadallahWisam @R_Phillips_3 @JagpreetNanda @PCuroMD mmgrabow https://t.co/PKba4Cyg5j https://t.co/e
RT @MCT_AACR: Three genes— ACAT1, MAP3K11, and PSMD12— support #enzalutamide resistance in in castration-resistant #ProstateCancer cells in…
RT @MCT_AACR: Three genes— ACAT1, MAP3K11, and PSMD12— support #enzalutamide resistance in in castration-resistant #ProstateCancer cells in…
Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells in vitro | Molecular Cancer Therapeutics https://t.co/tUqZsMMo43
RT @CaP_pubs: Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells in vitro. 𝙈𝙤𝙡 𝘾𝙖𝙣𝙘…
RT @CaP_pubs: Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells in vitro. 𝙈𝙤𝙡 𝘾𝙖𝙣𝙘…
Hey that's us!
Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells in vitro. 𝙈𝙤𝙡 𝘾𝙖𝙣𝙘𝙚𝙧 𝙏𝙝𝙚𝙧. @mmgrabow #ProstateCancer https://t.co/kpyxmcAc3d
RT @MCT_AACR: Three genes— ACAT1, MAP3K11, and PSMD12— support #enzalutamide resistance in in castration-resistant #ProstateCancer cells in…
Three genes— ACAT1, MAP3K11, and PSMD12— support #enzalutamide resistance in in castration-resistant #ProstateCancer cells in vitro. @CWRUSOM @Sarah_Kohrt1 @AwadallahWisam @R_Phillips_3 @JagpreetNanda @PCuroMD mmgrabow https://t.co/AJ2BzTGLqq https://t.c
Another interesting research story from lab online finally.
RT @mmgrabow: Our enzalutamide resistance paper, led by @Sarah_Kohrt1 and @AwadallahWisam (look out for his grad school app!), is now onlin…
RT @mmgrabow: Our enzalutamide resistance paper, led by @Sarah_Kohrt1 and @AwadallahWisam (look out for his grad school app!), is now onlin…
RT @mmgrabow: Our enzalutamide resistance paper, led by @Sarah_Kohrt1 and @AwadallahWisam (look out for his grad school app!), is now onlin…
RT @mmgrabow: Our enzalutamide resistance paper, led by @Sarah_Kohrt1 and @AwadallahWisam (look out for his grad school app!), is now onlin…
RT @mmgrabow: Our enzalutamide resistance paper, led by @Sarah_Kohrt1 and @AwadallahWisam (look out for his grad school app!), is now onlin…
RT @mmgrabow: Our enzalutamide resistance paper, led by @Sarah_Kohrt1 and @AwadallahWisam (look out for his grad school app!), is now onlin…
Nice paper from @mmgrabow and team; better understanding of PC biology will hopefully help identify new therapeutic targets/strategies.
Our enzalutamide resistance paper, led by @Sarah_Kohrt1 and @AwadallahWisam (look out for his grad school app!), is now online at @MCT_AACR! We've added some data versus the preprint in the form of enzalutamide resistant cell lines, so check it out! https